Bayer Cropscience Stock

Bayer Cropscience Equity

The The Equity of Bayer Cropscience (BAYERCROP.NS) as of Jul 27, 2026 is 28.50 B INR. In the previous year, The Equity was 28.49 B INR — a change of 0.04% (higher).

Equity

28.50 BINR

YoY

0.04%

Last updated:

In 2026, Bayer Cropscience's equity was 28.50 B INR, a 0.04% increase from the 28.49 B INR equity in the previous year.

Access this data via the Eulerpool API

Bayer Cropscience Stock analysis

What does Bayer Cropscience do? Bayer CropScience Ltd is a company specializing in the production and distribution of pesticides, seeds, and other agricultural products. It is headquartered in Monheim am Rhein, Germany, and is a part of the Bayer Group. The history of Bayer CropScience dates back to 1863 when it was founded by Friedrich Bayer and Johann Friedrich Weskott in Wuppertal, Germany. Initially, the company produced dyes before specializing in the production of chemicals and medicines. Over the years, the company began to expand into other areas, including agriculture. Today, Bayer CropScience is a leading global provider of agricultural chemical products and is among the top 3 companies in the global seed market. The company operates in more than 120 countries and employs over 23,000 people. The business model of Bayer CropScience involves developing and marketing innovative agricultural chemical products and seed varieties that help farmers increase their yields and improve their competitiveness. The company caters to all types of agricultural operations, from small family farms to large agricultural corporations. The company has various business segments, including seeds, plant protection products, pest control products, and digital agriculture solutions. In the seed segment, Bayer CropScience offers a wide range of seed varieties for various crops and geographies, including corn, soybeans, wheat, cotton, and vegetables. In the plant protection products segment, the company produces a variety of products that assist farmers in combating pests and weeds. Some of the most well-known products include Roundup, the most widely used herbicide globally, and Caparol, an insecticide for combating harmful insects on crops. In addition to plant protection products, Bayer CropScience also offers pest control products, including those used for combating mice, rats, and other rodents, as well as solutions for pest control in buildings and other structures. Another important business segment of Bayer CropScience is digital agriculture solutions. The company provides solutions for the digitalization of agricultural operations, which help farmers improve their productivity and efficiency. The offered solutions include software for optimizing cultivation strategies and precision application of plant protection products. In recent years, Bayer CropScience has also focused on the development of solutions for sustainable agriculture and environmental protection. The company aims to make agriculture more sustainable and environmentally friendly by offering innovative solutions for plant protection and seed development that are less harmful to the environment. Overall, Bayer CropScience is a key player in the global agricultural market, focusing on the development and marketing of innovative agricultural chemical products and seed varieties. The company offers a wide range of products and solutions for agriculture, which contribute to improving the productivity and efficiency of agricultural operations worldwide. Bayer Cropscience is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Bayer Cropscience's Equity

Bayer Cropscience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bayer Cropscience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bayer Cropscience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bayer Cropscience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bayer Cropscience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bayer Cropscience stock

The Equity of Bayer Cropscience is 28.50 B INR in 2026.

Access this data via the Eulerpool API

Balance Sheet — Bayer Cropscience

All Key Metrics — Bayer Cropscience